Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Gynecologic Oncology|January 22, 2005
A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinomaM F Kose, J Sufliarsky, S Beslija, et al.Breast (Edinburgh, Scotland)|August 20, 2013
Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: a multicentric Turkish Oncology Group (TOG) trialP Saip, Y Eralp, F Sen, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 17, 2007
MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancerY Eralp, D Derin, Y Ozluk, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 7, 2014
Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?S Karabulut, E Akşit, F Tas, et al.British Journal of Cancer|August 23, 2000
BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patientsH Yazici, O Bitisik, E Akisik, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 15, 2012
The access rate to diagnosis and treatment modalities in breast cancer patients in Turkey; multicenter observational studyP Saip, S Keskin, M Ozkan, et al.Pageof 3